bpc-157 human clinical trial safety trials evidence review regulatory status bpc-157 human trials safety Multifunctionality Most FDA advisers say the – bpc-157 human clinical trial safety

M.et al (2009)

Humanaut is second to none

Harlan E

Fatigue is often caused by an inability to transport enough oxygen to your bodys cells

Batch: GF-BPCTB5-B241 BPC-157 Assay: 7.36 mg BPC-157 Purity: 99.2 percent BPC-157 Identification by RT: 0.995 Molecular Ion Mass Identification (BPC-157): 1418 Da TB-500 Assay: 6.11 mg TB-500 Purity: greater than 99.8 percent TB-500 Identification by RT: 0.996 Molecular Ion Mass Identification (TB-500): 4963 Da Bacterial Endotoxins: below 0.001 EU/mg Total Aerobic Microbial Count: Not detected Total Yeast and Mold Count: Not detected Research Applications In controlled laboratory environments, BPC-157 / TB-500 may be utilised in experimental models designed to investigate peptide signalling systems and molecular interaction pathways